Anavex Life Sciences Corp (AVXL)

[Joseph_K]

Wouldn't you want Anavex determining the dosage first? Physicians prescribing off-label, patient by patient, on an ad hoc basis doesn't sound like a great system.

When blarcamesine shows wonderful results with girls with Rett, whose muscle control problems are then fixed, just have physicians prescribe blarcamesine off-label for patients with hereditary spastic paraplegia (HSP), even though it hasn't been directly approved for that rare disease yet. Makes sense.

Consider, e.g., how different the Rett and AD dosages are.